Mumbai, Sep 8 (FN Representative) Allurion, a company dedicated to ending obesity, has launched the Allurion Swallowable Capsule in India – the only medical weight-loss device fully approved by the Central Drugs Standard Control Organisation (CDSCO), the national regulatory authority of India overseen by the Ministry of Health & Family Welfare’s Directorate General of Health Services. The Allurion Swallowable Capsule is the world’s first and only swallowable, procedureless gastric balloon for weight loss. The capsule is paired with the Allurion Virtual Care Suite, a remote patient monitoring solution powered by the Allurion Iris AI platform that includes the Allurion Mobile app, connected scale and health tracker, a release issued here stated. In just a 15-minute clinic visit, the patient swallows the Allurion Swallowable Capsule – a safe and temporary vegan capsule that contains a deflated gastric balloon.
Once in the stomach, a healthcare professional uses a catheter to inflate the balloon with 550 ml of liquid – no surgery, endoscopy or anaesthesia is required. A simple X-ray is used to ensure the balloon is in the right position. After placement, the balloon – roughly the size of a grapefruit – takes up space in the patient’s stomach, creating a feeling of fullness and reducing food intake. The balloon reduces feelings of hunger, and in approximately 16 weeks, it automatically deflates and passes out of the body naturally. The total expenditure of this treatment is Rs three lakh. The Allurion Programme has been developed by Dr Shantanu Gaur together with his partner and former Harvard professor Dr Ram Chuttani with a goal to end obesity, the release added.